Henry A. Dunn

Henry A. Dunn

Auto-generated profile, based on publicly available information

Henry A. Dunn

Department of Neuroscience, The Scripps Research Institute, Jupiter, FL 33458

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2012 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
AMAna C Magalhaes
Ana C Magalhaes
HDHenry Dunn
Henry Dunn
SFStephen Sg Ferguson
Stephen Sg Ferguson

1 October 2015 in Molecular Pharmacology
Verified
Journal Article
Open access
PDF file
HDHenry A. Dunn
Henry A. Dunn
SFStephen S.G. Ferguson
Stephen S.G. Ferguson
G protein-coupled receptors (GPCRs) contribute to the regulation of every aspect of human physiology and are the therapeutic targets for the treatment of numerous diseases. As a consequence, understanding the myriad of mechanisms controlling GPCR signalling and trafficking is essential for the development of new pharmacological strategies for the treatment of human pathologies. Of the many GPCR-interacting proteins (GIPs), PDZ domain-containing proteins appear most abundant and have similarly been implicated in disease mechanisms. PDZ proteins play an important role at regulating receptor and channel protein localization of synapses and tight junctions and function to scaffold intracellular signalling protein complexes. In the current study, we review the known functional interactions between PDZ domain-containing proteins and GPCRs, and provide insight into the potential mechanisms of action. These PDZ domain-containing proteins include the membrane-associated guanylate-like kinases (MAGUKs) (PSD-95, SAP97, PSD-93, SAP102, DLG5, CARMA3, MPP3, CASK, MAGI-1, MAGI-2, MAGI-3), NHERF proteins (NHERF1, NHERF2, PDZK1, PDZK2), Golgi-associated PDZ proteins (GIPC and CAL), PDZ-GEFs (PDZ-GEF1 and PDZ-GEF2), RGS-Homology-RhoGEFs (PDZ-RhoGEF and LARG), RGS3 and RGS12, spinophilin and neurabin-1, Shank proteins (Shank1, Shank2, Shank3), Par3 and Par6, MUPP1, Tamalin, nNOS, PICK1, and SNX27.

23 April 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HDHenry A. Dunn
Henry A. Dunn
DPDipak N. Patil
Dipak N. Patil
YCYan Cao
Yan Cao
COCesare Orlandi
Cesare Orlandi
KMKirill A. Martemyanov
Kirill A. Martemyanov
Significance: G protein-coupled receptors (GPCRs) continue to be the pharmaceutical target of over one-third of FDA-approved drugs, yet our understanding of GPCR function has been overwhelmingly limited to the study of intracellular effectors. It is emerging that GPCRs also associate with a variety of extracellular proteins, yet the functional consequences of these interactions have been ill defined for the lack of robust approaches to measure them. In this study, we develop a unique assay platform and provide an example of transcellular modulation of GPCR properties by association with a synaptic adhesion molecule.

4 September 2019 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
HDHenry A. Dunn
Henry A. Dunn
SZStefano Zucca
Stefano Zucca
MDMaria Dao
Maria Dao
COCesare Orlandi
Cesare Orlandi
KMKirill A. Martemyanov
Kirill A. Martemyanov

1 October 2019 in Pharmacological Reviews
Verified
Journal Article
Closed access
PDF file
HDHenry A. Dunn
Henry A. Dunn
COCesare Orlandi
Cesare Orlandi
KMKirill A. Martemyanov
Kirill A. Martemyanov
G protein–coupled receptors (GPCRs) remain one of the most successful targets of U.S. Food and Drug Administration–approved drugs. GPCR research has predominantly focused on the characterization of the intracellular interactome’s contribution to GPCR function and pharmacology. However, emerging evidence uncovers a new dimension in the biology of GPCRs involving their extracellular and transcellular interactions that critically impact GPCR function and pharmacology. The seminal examples include a variety of adhesion GPCRs, such as ADGRLs/latrophilins, ADGRBs/brain angiogenesis inhibitors, ADGRG1/GPR56, ADGRG6/GPR126, ADGRE5/CD97, and ADGRC3/CELSR3. However, recent advances have indicated that class C GPCRs that contain large extracellular domains, including group III metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7, mGluR8), γ-aminobutyric acid receptors, and orphans GPR158 and GPR179, can also participate in this form of transcellular regulation. In this review, we will focus on a variety of identified extracellular and transcellular GPCR-interacting partners, including teneurins, neurexins, integrins, fibronectin leucine-rich transmembranes, contactin-6, neuroligin, laminins, collagens, major prion protein, amyloid precursor protein, complement C1q-likes, stabilin-2, pikachurin, dystroglycan, complement decay-accelerating factor CD55, cluster of differentiation CD36 and CD90, extracellular leucine-rich repeat and fibronectin type III domain containing 1, and leucine-rich repeat, immunoglobulin-like domain and transmembrane domains. We provide an account on the diversity of extracellular and transcellular GPCR complexes and their contribution to key cellular and physiologic processes, including cell migration, axon guidance, cellular and synaptic adhesion, and synaptogenesis. Furthermore, we discuss models and mechanisms by which extracellular GPCR assemblies may regulate communication at cellular junctions. SIGNIFICANCE STATEMENT G protein–coupled receptors (GPCRs) continue to be the prominent focus of pharmacological intervention for a variety of human pathologies. Although the majority of GPCR research has focused on the intracellular interactome, recent advancements have identified an extracellular dimension of GPCR modulation that alters accepted pharmacological principles of GPCRs. Herein, we describe known endogenous allosteric modulators acting on GPCRs both in cis and in trans.

2 September 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YCYan Cao
Yan Cao
YWYuchen Wang
Yuchen Wang
HDHenry A. Dunn
Henry A. Dunn
COCesare Orlandi
Cesare Orlandi
NSNicole Shultz
Nicole Shultz
KMKirill A. Martemyanov
Kirill A. Martemyanov
Significance: Humans, like most diurnal species, utilize cone photoreceptors to enable daylight vision. They detect color, cover a wide range of light intensities, and sustain fast responsiveness to faithfully sample rapidly changing scenery. All of these features that allow us to accurately see the world depend on the ability of cones to transmit their light-evoked signals to the brain. For this, cones form functional contacts with their downstream neurons—a process known as “synaptic wiring.” The molecular mechanisms that mediate establishment of cone synaptic contacts are largely unknown. Our studies fill this gap by identifying a set of molecules involved in functional wiring of cones.